Queisser Pharma is a German company focused on the OTC market through food supplements and medical devices. Its general manager for Turkey, Demet Eryilmaz, tells the “special” story of its major brand Doppelherz, analyzes the regulatory environment for OTC products in the country, and explains how the pandemic has transformed the sector.
Perhaps because of the pandemic, the population has taken a closer look at their health and lifestyle, understanding that being healthy can be the difference between life or death during unexpected emergencies, not only in the long term
